|
|
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
霜叶: 金币+15, 翻译EPI+1, ★★★★★最佳答案, 非常感谢，剩余的麻烦帮我再翻译，谢谢啦 我已追加金币 2013-03-26 18:15:44
霜叶(phu_grassman代发): 金币+10 2013-04-14 09:52:13
OBJECTIVES:
目标：
Some large population-based studies have reported a dose-related increased risk of cataracts and glaucoma associated with use of inhaled corticosteroids (ICS) in patients with asthma or chronic obstructive pulmonary disease (COPD).
We evaluated the association between use of ICS-containing products, specifically fluticasone propionate/salmeterol fixed-dose combination (FSC), and incidence of cataracts and glaucoma among patients with COPD in a large electronic medical record database in the United Kingdom. 一些基于大量人群的研究报告称，在患有哮喘或慢性阻塞性肺疾病(COPD)的病人发生白内障和青光眼的风险，与他们使用吸入式糖皮质激素(ICS)存在剂量递增性。我们评估了使用含吸入式糖皮质激素(ICS)产品，特别是丙酸氟替卡松/沙美特罗定量组合(FSC)，与大英帝国一个大型电子医疗记录数据库中慢性阻塞性肺病患者 白内障和青光眼发生率的关系。
METHODS:
方法：
We identified a cohort of patients aged 45 years and over with COPD in the General Practice Research Database (GPRD) between 2003 and 2006.
Cases of incident cataracts or glaucoma were defined based on diagnosis and procedure codes and matched to controls from the risk set to estimate odds ratios (OR) and 95% confidence intervals (CI). 在研究数据库(GPRD)中处于2003到2006年这段期间里，我们发现了一个年龄为45岁且患有COPD的同期组群。白内障或青光眼的发生病例通过诊断和程序编码来确定，并结合通过控制风险设定来计算比值比（OR）和置信区间为95%。
先这么多吧 、、确实不好翻译 |
|
回复此楼